Trials / Unknown
UnknownNCT01205009
Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- Female
- Age
- 40 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
In an era of delayed fertility plans, there is increasing need for fertility treatment in older women with poor response. Human chorionic gonadotropin (hCG) supplementation prior to treatment, as a thecal stimulant, may improve folliculogenesis and ovarian response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ovitrelle | One dose of Ovitrelle 250 mcg |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-03-01
- First posted
- 2010-09-20
- Last updated
- 2011-03-02
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01205009. Inclusion in this directory is not an endorsement.